MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts payable and accrued lia...
Proceeds from the issuance of no...
Other current assets
Others
Negative Cash Flow Breakdown
Net loss
Gain on remeasurement of deferre...
Payments made on notes payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-605
-500
-5,174
3,214
Bad debt expense
0
-
3
2
Depreciation
2
2
3
2
Amortization of debt issuance costs and discounts
40
48
55
54
Stock-based compensation
-
-
377
-
Stock based compensation
11
-284
-
22
Change in fair value of derivatives
9
13
19
-37
Change in fair value of deferred compensation conversion liability
-
217
-
-
Gain on remeasurement of deferred compensation conversion liability
222
-
-
-
Amortization of lease right-of-use-asset
24
22
25
25
Loss on extinguishment of debt
-
-
-
-138
Inducement charge for warrants issued
0
78
-
-
Gain from forgiveness of debt
0
3
50
46
Loss on extinguishment of debt
0
0
-501
-
Other non-cash expenses
6
6
12
8
Accounts receivable
0
0
0
0
Inventory
31
21
-135
-12
Other current assets
-58
-21
-33
-25
Accounts payable and accrued liabilities
192
-97
832
204
Lease liabilities
-2
-11
-22
-27
Deferred revenue
0
0
-500
10
Net cash used in operating activities
-319
-617
-291
-277
Purchase of property and equipment
-
-
0
2
Net cash used for investing activities
-
-
0
-2
Proceeds from private placement offerings
-
-
-
260
Proceeds from warrant exercises
0
980
-
-
Proceeds from the issuance of notes payable
107
188
125
108
Proceeds from the issuance of notes payable issued to related parties
-
-
0
160
Payments made on notes payable
128
215
187
94
Payments made on notes payable issued to related parties
0
2
10
31
Payments of debt issuance costs
17
28
-32
62
Proceeds from issuance of common stock and warrants in private placement offerings
0
0
567
-
Net cash provided by financing activities
-38
923
267
181
Net change in cash and cash equivalents
-357
306
-24
-98
Cash at beginning of period
369
63
87
388
Cash at end of period
12
369
63
87
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net change in cash
and cash...
-$357K
(-75.86%↓ Y/Y)
something is missing
$217K
Accounts payable and
accrued liabilities
$192K
(-41.28%↓ Y/Y)
Other current assets
-$58K
(61.33%↑ Y/Y)
Amortization of debt issuance
costs and discounts
$40K
(-70.37%↓ Y/Y)
Amortization of lease
right-of-use-asset
$24K
(-48.94%↓ Y/Y)
Stock based
compensation
$11K
(-96.67%↓ Y/Y)
Other non-cash
expenses
$6K
(-53.85%↓ Y/Y)
Depreciation
$2K
(-60.00%↓ Y/Y)
Proceeds from the
issuance of notes payable
$107K
(-69.86%↓ Y/Y)
Net cash used in
operating activities
-$319K
(36.20%↑ Y/Y)
Net cash provided by
financing activities
-$38K
(-112.79%↓ Y/Y)
Canceled cashflow
$550K
Canceled cashflow
$107K
Net loss
-$605K
(51.05%↑ Y/Y)
Payments made on notes
payable
$128K
(-41.28%↓ Y/Y)
Gain on
remeasurement of deferred...
$222K
Inventory
$31K
(181.58%↑ Y/Y)
Change in fair value of
derivatives
$9K
(-89.16%↓ Y/Y)
Lease liabilities
-$2K
(96.08%↑ Y/Y)
Payments of debt issuance
costs
$17K
(-62.22%↓ Y/Y)
Buy us a coffee
GUIDED THERAPEUTICS INC (GTHP)
GUIDED THERAPEUTICS INC (GTHP)